Healthcare · Diagnostics & Research

Sai Life Sciences Ltd.

SAILIFE

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

NSE: SAILIFEOfficial website ↗

Key metrics

Market Cap

₹21,157 cr

P/E Ratio

63.31x

P/B Ratio

9.94x

ROE

7.99%

ROCE

12.25%

Debt / Equity

0.17x

Net Margin

10.25%

Dividend Yield

—

EPS

₹8.61

Period

FY2025

Shareholding pattern

As of Latest

Promoter: 38.09%FII: 41.49%Public: 20.42%

Deep-dive pages

10-Year Financials→Shareholding Pattern→Dividends & Corporate Actions→

Educational content — not investment adviceThis page presents publicly available information about Sai Life Sciences Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.